TY - JOUR
T1 - Estimating treatment coverage for people with substance use disorders
T2 - an analysis of data from the World Mental Health Surveys
AU - on behalf of the World Health Organization's World Mental Health Surveys collaborators
AU - Degenhardt, Louisa
AU - Glantz, Meyer
AU - Evans-Lacko, Sara
AU - Sadikova, Ekaterina
AU - Sampson, Nancy
AU - Thornicroft, Graham
AU - Aguilar-Gaxiola, Sergio
AU - Al-Hamzawi, Ali
AU - Alonso, Jordi
AU - Helena Andrade, Laura
AU - Bruffaerts, Ronny
AU - Bunting, Brendan
AU - Bromet, Evelyn J.
AU - Caldas de Almeida, José Miguel
AU - de Girolamo, Giovanni
AU - Florescu, Silvia
AU - Gureje, Oye
AU - Maria Haro, Josep
AU - Huang, Yueqin
AU - Karam, Aimee
AU - Karam, Elie G.
AU - Kiejna, Andrzej
AU - Lee, Sing
AU - Lepine, Jean Pierre
AU - Levinson, Daphna
AU - Elena Medina-Mora, Maria
AU - Nakamura, Yosikazu
AU - Navarro-Mateu, Fernando
AU - Pennell, Beth Ellen
AU - Posada-Villa, José
AU - Scott, Kate
AU - Stein, Dan J.
AU - ten Have, Margreet
AU - Torres, Yolanda
AU - Zarkov, Zahari
AU - Chatterji, Somnath
AU - Kessler, Ronald C.
AU - Adamowski, Tomasz
AU - Al-Kaisy, Mohammad
AU - Altwaijri, Yasmin
AU - Atwoli, Lukoye
AU - Auerbach, Randy P.
AU - Axinn, William G.
AU - Benjet, Corina
AU - Borges, Guilherme
AU - Cardoso, Graça
AU - Chardoul, Stephanie
AU - Filho, Alexandre Chiavegatto
AU - Cia, Alfredo H.
AU - Cuijpers, Pim
N1 - Publisher Copyright:
© 2017 World Psychiatric Association
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality (“minimally adequate treatment”). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.
AB - Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality (“minimally adequate treatment”). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.
KW - Substance use disorders
KW - United Nations Sustainable Development Goals
KW - World Health Organization
KW - alcohol
KW - drugs
KW - treatment coverage
UR - http://www.scopus.com/inward/record.url?scp=85029725127&partnerID=8YFLogxK
U2 - 10.1002/wps.20457
DO - 10.1002/wps.20457
M3 - Article
AN - SCOPUS:85029725127
SN - 1723-8617
VL - 16
SP - 299
EP - 307
JO - World Psychiatry
JF - World Psychiatry
IS - 3
ER -